Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/14/2024 | $5.00 | Buy | Rodman & Renshaw |
| 1/18/2022 | $5.00 → $3.00 | Buy | HC Wainwright & Co. |
| 9/7/2021 | $5.50 → $5.00 | Buy | HC Wainwright & Co. |
Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that the Company appointed Joe Dawson to its board of directors. Additionally, Andrea Heslin Smiley has resigned from the Company's board of directors to pursue other endeavors. "We are pleased to welcome Joe to Rockwell Medical's board of directors. Joe is a seasoned executive who has extensive operational experience, a strong network in the renal care space, and deep domain expertise in building and scaling commercial organizations," said Robert S. Radie, Chairman of t
Net sales for the third quarter 2025 were $15.9 million. Company reiterates 2025 guidance for net sales to be between $65 million and $70 million. Achieved profitability on an Adjusted EBITDA basis for the third quarter 2025. Increased cash position to $23.7 million at September 30, 2025. Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced financial and operational results for the three and nine months ended September 30, 2025. "During the third quarter, we continued to right-size our organization to enhance ope
Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that Rashad Brown has joined the Company as Vice President, Manufacturing and Supply Chain. Mr. Brown brings more than two decades of leadership experience in manufacturing operations, procurement, warehouse management, and supply chain optimization within regulated healthcare manufacturing environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251111461038/en/Rashad Brown - Vice President, Manufacturing
4 - ROCKWELL MEDICAL, INC. (0001041024) (Issuer)
3 - ROCKWELL MEDICAL, INC. (0001041024) (Issuer)
4 - ROCKWELL MEDICAL, INC. (0001041024) (Issuer)
8-K - ROCKWELL MEDICAL, INC. (0001041024) (Filer)
8-K - ROCKWELL MEDICAL, INC. (0001041024) (Filer)
10-Q - ROCKWELL MEDICAL, INC. (0001041024) (Filer)
Rodman & Renshaw initiated coverage of Rockwell Medical with a rating of Buy and set a new price target of $5.00
HC Wainwright & Co. reiterated coverage of Rockwell Medical with a rating of Buy and set a new price target of $3.00 from $5.00 previously
HC Wainwright & Co. reiterated coverage of Rockwell Medical with a rating of Buy and set a new price target of $5.00 from $5.50 previously
4 - ROCKWELL MEDICAL, INC. (0001041024) (Issuer)
Net sales for the third quarter 2025 were $15.9 million. Company reiterates 2025 guidance for net sales to be between $65 million and $70 million. Achieved profitability on an Adjusted EBITDA basis for the third quarter 2025. Increased cash position to $23.7 million at September 30, 2025. Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced financial and operational results for the three and nine months ended September 30, 2025. "During the third quarter, we continued to right-size our organization to enhance ope
Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that it will release its financial and operational results for the third quarter ended September 30, 2025 on Wednesday, November 12, 2025. The Company will issue a press release at 6:00am ET followed by a live conference call and webcast at 8:00am ET. CONFERENCE CALL AND WEBCAST DETAILS Date: Wednesday, November 12, 2025 Time: 8:00am ET Live Number: (888) 660-6347 // (International) 1 (929) 201-6594 Conference Call ID: 4944610 Webcast and Replay: www.RockwellMe
Generated $1.8 million in cash flow from operations for the second quarter of 2025. Reported gross margin of 16% for the second quarter of 2025, in line with 2025 guidance. Increased cash position at June 30, 2025 to $18.4 million. Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced financial and operational results for the three and six months ended June 30, 2025. "During the second quarter of 2025, we successfully managed through the transition of our largest customer away from Rockwell Medical and now find ou
Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that the Company appointed Joe Dawson to its board of directors. Additionally, Andrea Heslin Smiley has resigned from the Company's board of directors to pursue other endeavors. "We are pleased to welcome Joe to Rockwell Medical's board of directors. Joe is a seasoned executive who has extensive operational experience, a strong network in the renal care space, and deep domain expertise in building and scaling commercial organizations," said Robert S. Radie, Chairman of t
Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that Rashad Brown has joined the Company as Vice President, Manufacturing and Supply Chain. Mr. Brown brings more than two decades of leadership experience in manufacturing operations, procurement, warehouse management, and supply chain optimization within regulated healthcare manufacturing environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251111461038/en/Rashad Brown - Vice President, Manufacturing
Universal Display Corporation (NASDAQ:OLED) (UDC), enabling energy-efficient displays and lighting with its UniversalPHOLED® technology and materials, today announced that Dr. Nigel Brown and Dr. Joan Lau have joined the Company's Board of Directors, effective March 4, 2024. The addition of these new directors expands UDC's Board to ten members. "I am pleased to welcome Nigel and Joan to the Board," said Steven V. Abramson, President and Chief Executive Officer of Universal Display Corporation and a member of the Board. "Nigel adds a wealth of business innovation, technical knowledge and corporate strategic planning expertise to our Board. Joan brings over two decades of extensive scienti
SC 13G/A - ROCKWELL MEDICAL, INC. (0001041024) (Subject)
SC 13G/A - ROCKWELL MEDICAL, INC. (0001041024) (Subject)
SC 13D/A - ROCKWELL MEDICAL, INC. (0001041024) (Subject)